Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GPN vs GSK✓SelectedUSD · GSKGPN vs GSK performance historyLatest closeAs of-2.26%11/16
Stock and ETF performance explorer

GPN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+25.4%
GSK return
+9.7%
Excess return
+15.7%
Maximum drawdown
-24.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.3%-0.1%-2.2%-2.2%
7D-8.1%-1.3%-6.8%-7.8%
30D+7.4%+2.7%+4.6%+6.4%
3M-3.2%+2.7%-5.9%-4.1%
6M+33.8%+3.3%+30.5%+32.3%
YTD+17.2%+6.5%+10.7%+10.2%
All+25.4%+9.7%+15.7%+15.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling